
Insumark M 1mg/500mg Tablet SR
Marketer
Trimark Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Insumark M 1mg/500mg Tablet SR
Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance can elevate blood sugar, increasing risks of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight control as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Recognize these symptoms and know how to manage them with readily available glucose sources like sugary snacks or juice. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also a potential consequence. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Insumark M 1mg/500mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Insumark M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Insumark M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Insumark M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Consume this extended-release tablet with a meal.
Common Side effects of Insumark M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Insumark M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Insumark M 1mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with food.
How Insumark M 1mg/500mg Tablet SR works:
Insumark M 1mg/500mg Extended-Release tablets combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Insumark M 1mg/500mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Insumark M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.
Breast feedingUNSAFE
Extended-release Insumark M tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to the potential for infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Insumark M 1mg/500mg SR tablets, potentially requiring dosage modification. Medical consultation is essential. This medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Insumark M 1mg/500mg Tablet SR. Dosage modifications for Insumark M 1mg/500mg Tablet SR may be necessary; physician consultation is advised. A low initial dose of Insumark M 1mg/500mg Tablet SR is typically prescribed for those with mild to moderate liver disease; its use is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Insumark M 1mg/500mg Tablet SR :
Should you forget to take a dose of Insumark M 1mg/500mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Insumark M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
